Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atherogenic Dyslipidemia”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Testing effectiveness (Phase 2)Study completedNCT01271751
What this trial is testing

Pilot Study With GFT505 (80mg) in Atherogenic Dyslipidaemic Patients With Abdominal Obesity

Who this might be right for
Atherogenic DyslipidaemiaAbdominal Obesity
Genfit 96
Testing effectiveness (Phase 2)Study completedNCT00345410
What this trial is testing

Dose-Ranging Study Evaluating AVE1625 in Abdominally Obese Patients With Atherogenic Dyslipidemia

Who this might be right for
ObesityDyslipidemia
Sanofi 345
Large-scale testing (Phase 3)Study completedNCT00239967
What this trial is testing

An International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese Patients

Who this might be right for
DyslipidemiaObesity
Sanofi 803
Very early researchLooking for participantsNCT06494488
What this trial is testing

Differential Thrombogenesis by EPA and DHA Mediated by HDL

Who this might be right for
Lipid Metabolism DisordersHypertriglyceridemia
The Miriam Hospital 80
Not applicableStudy completedNCT03172611
What this trial is testing

A Defined, Plant-based, 4-week Dietary Intervention Reduces Lp(a) and Other Atherogenic Particles

Who this might be right for
Hypercholesterolemia
Texas Woman's University 33
Not applicableStudy completedNCT01250990
What this trial is testing

Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis

Who this might be right for
Dyslipidemias
University of Pennsylvania 22
Not applicableStudy completedNCT01792648
What this trial is testing

Effects of Almond Intake on Atherogenic Lipoprotein Particles

Who this might be right for
DyslipidemiaObesity, Abdominal
UCSF Benioff Children's Hospital Oakland 24
Not applicableStudy completedNCT00852267
What this trial is testing

Lipoprotein Effects of Substituting Beef Protein for Carbohydrate

Who this might be right for
HealthyCardiovascular DiseaseAtherogenic Dyslipidemia
UCSF Benioff Children's Hospital Oakland 67
Not applicableLooking for participantsNCT05090878
What this trial is testing

Atherogenic Lipoproteins in Ischemic Stroke

Who this might be right for
Ischemic Stroke
University Hospital, Basel, Switzerland 500
Not applicableEnrolling By InvitationNCT04209816
What this trial is testing

Genetic Pathways Leading to Fatty Liver and Atherogenic Dyslipidemia

Who this might be right for
Non-alcoholic Fatty LiverAtherogenic DyslipidemiaInsulin Resistance
Marja-Riitta Taskinen 100
Not applicableStudy completedNCT00895141
What this trial is testing

Effect of Saturated Fat on Large Low-density Lipoprotein (LDL) and High-density Lipoprotein (HDL)

Who this might be right for
Dyslipidemia
UCSF Benioff Children's Hospital Oakland 53
Not applicableStudy completedNCT01027325
What this trial is testing

Resistant Starch Insulin Sensitivity Trial

Who this might be right for
HealthyCardiovascular DiseaseAtherogenic Dyslipidemia+1 more
UCSF Benioff Children's Hospital Oakland 52
Large-scale testing (Phase 3)Study completedNCT00639158
What this trial is testing

Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood

Who this might be right for
DyslipidemiasCoronary Heart DiseaseCombined (Atherogenic) Dyslipidemia+1 more
Abbott 543
Not applicableStudy completedNCT05001126
What this trial is testing

The Dose-response Effects of High Intensity Functional Training on Metabolic Syndrome Risk Factors

Who this might be right for
Metabolic SyndromeAtherogenic DyslipidemiaInsulin Resistance+1 more
Gary Van Guilder 25
Not applicableStudy completedNCT01363141
What this trial is testing

Effect of a Low Advanced Glycation End Products (AGE) Diet in the Metabolic Syndrome

Who this might be right for
Metabolic Syndrome
Icahn School of Medicine at Mount Sinai 383
Testing effectiveness (Phase 2)Study completedNCT00400231
What this trial is testing

The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study

Who this might be right for
Metabolic Syndrome x
University of Pennsylvania 124
Not applicableStudy completedNCT01427855
What this trial is testing

Dietary Protein Sources and Atherogenic Dyslipidemia

Who this might be right for
Cardiovascular DiseaseDyslipidemiaInsulin Resistance+1 more
UCSF Benioff Children's Hospital Oakland 113
Large-scale testing (Phase 3)Study completedNCT02476006
What this trial is testing

Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)

Who this might be right for
Hypercholesterolemia
Sanofi 998
Not applicableStudy completedNCT02181244
What this trial is testing

Egg Effects on Atherogenic Dyslipidemias, Glucose Metabolism and Inflammation in Diabetic Subjects

Who this might be right for
Diabetes MellitusInflammation
University of Connecticut 33
Testing effectiveness (Phase 2)Study completedNCT00116519
What this trial is testing

A Study in People With Abnormal Fat Levels in the Blood

Who this might be right for
Dyslipidemia
Eli Lilly and Company 300
Load More Results